BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17764935)

  • 21. Synthesis of fluorine substituted pyrazolopyrimidines as potential leads for the development of PET-imaging agents for the GABAA receptors.
    Hoepping A; Diekers M; Deuther-Conrad W; Scheunemann M; Fischer S; Hiller A; Wegner F; Steinbach J; Brust P
    Bioorg Med Chem; 2008 Feb; 16(3):1184-94. PubMed ID: 18023192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computationally identified novel diphenyl- and phenylpyridine androgen receptor antagonist structures.
    Söderholm AA; Viiliäinen J; Lehtovuori PT; Eskelinen H; Roell D; Baniahmad A; Nyrönen TH
    J Chem Inf Model; 2008 Sep; 48(9):1882-90. PubMed ID: 18712859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of Tpl2 kinase and TNFalpha production with quinoline-3-carbonitriles for the treatment of rheumatoid arthritis.
    Hu Y; Green N; Gavrin LK; Janz K; Kaila N; Li HQ; Thomason JR; Cuozzo JW; Hall JP; Hsu S; Nickerson-Nutter C; Telliez JB; Lin LL; Tam S
    Bioorg Med Chem Lett; 2006 Dec; 16(23):6067-72. PubMed ID: 16973359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of p-carborane-based nonsteroidal progesterone receptor antagonists.
    Fujii S; Nakano E; Yanagida N; Mori S; Masuno H; Kagechika H
    Bioorg Med Chem; 2014 Oct; 22(19):5329-37. PubMed ID: 25151087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of indole-containing tetracycles as a new scaffold for androgen receptor ligands.
    Zhang X; Li X; Allan GF; Musto A; Lundeen SG; Sui Z
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3233-7. PubMed ID: 16603353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and SAR of novel hydantoin derivatives as selective androgen receptor modulators.
    Zhang X; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5763-6. PubMed ID: 16959487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and evaluation of cis-3,4-disubstituted piperidines as potent CC chemokine receptor 2 (CCR2) antagonists.
    Cherney RJ; Nelson DJ; Lo YC; Yang G; Scherle PA; Jezak H; Solomon KA; Carter PH; Decicco CP
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5063-5. PubMed ID: 18722120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular basis of agonicity and antagonicity in the androgen receptor studied by molecular dynamics simulations.
    Bisson WH; Abagyan R; Cavasotto CN
    J Mol Graph Model; 2008 Nov; 27(4):452-8. PubMed ID: 18805032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the substituent effects on a novel series of C1'-dimethyl-aryl Delta8-tetrahydrocannabinol analogs.
    Krishnamurthy M; Gurley S; Moore BM
    Bioorg Med Chem; 2008 Jul; 16(13):6489-500. PubMed ID: 18524604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effects of chlormadinone acetate and its 3alpha- and 3beta-hydroxy metabolites on progesterone, androgen and glucocorticoid receptors.
    Schneider J; Kneip C; Jahnel U
    Pharmacology; 2009; 84(2):74-81. PubMed ID: 19590256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of novel isoquinoline-3-nitriles as orally bioavailable Kv1.5 antagonists for the treatment of atrial fibrillation.
    Trotter BW; Nanda KK; Kett NR; Regan CP; Lynch JJ; Stump GL; Kiss L; Wang J; Spencer RH; Kane SA; White RB; Zhang R; Anderson KD; Liverton NJ; McIntyre CJ; Beshore DC; Hartman GD; Dinsmore CJ
    J Med Chem; 2006 Nov; 49(24):6954-7. PubMed ID: 17125248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
    Hodgson MC; Astapova I; Hollenberg AN; Balk SP
    Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel C-6 substituted and unsubstituted pregnane derivatives as 5alpha-reductase inhibitors and their effect on hamster flank organs diameter size.
    Cabeza M; Zambrano A; Heuze I; Carrizales E; Palacios A; Segura T; Valencia N; Bratoeff E
    Steroids; 2009 Oct; 74(10-11):793-802. PubMed ID: 19406144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A bioisosteric approach to the discovery of indole carbinol androgen receptor ligands.
    Lanter JC; Fiordeliso JJ; Allan GF; Musto A; Hahn do W; Sui Z
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5646-9. PubMed ID: 16942875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of dihydroquinoxalinone acetamides containing bicyclic amines as potent Bradykinin B1 receptor antagonists.
    Chen JJ; Qian W; Biswas K; Viswanadhan VN; Askew BC; Hitchcock S; Hungate RW; Arik L; Johnson E
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4477-81. PubMed ID: 18674903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SAR studies of 6-(arylamino)-4,4-disubstituted-1-methyl-1,4-dihydro-benzo[d][1,3]oxazin-2-ones as progesterone receptor antagonists.
    Kern JC; Terefenko EA; Fensome A; Unwallla R; Wrobel J; Zhu Y; Cohen J; Winneker R; Zhang Z; Zhang P
    Bioorg Med Chem Lett; 2007 Jan; 17(1):189-92. PubMed ID: 17027272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and synthesis of carborane-containing androgen receptor (AR) antagonist bearing a pyridine ring.
    Ohta K; Goto T; Fijii S; Suzuki T; Ohta S; Endo Y
    Bioorg Med Chem; 2008 Sep; 16(17):8022-8. PubMed ID: 18707892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-activity relationships of xanthocillin derivatives as thrombopoietin receptor agonist.
    Yamaguchi T; Miyake Y; Miyamura A; Ishiwata N; Tatsuta K
    J Antibiot (Tokyo); 2006 Nov; 59(11):729-34. PubMed ID: 17256473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
    Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ
    Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-(3-Cyclopentyl-2-thioxo-2,3-dihydro-1H-benzimidazol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile: A novel, highly potent, selective, and orally active non-steroidal progesterone receptor agonist.
    Zhang P; Terefenko E; Kern J; Fensome A; Trybulski E; Unwalla R; Wrobel J; Lockhead S; Zhu Y; Cohen J; Lacava M; Winneker RC; Zhang Z
    Bioorg Med Chem; 2007 Oct; 15(20):6556-64. PubMed ID: 17681796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.